NDC 80353-702

Prostazen

Enlarged Prostate, Prostatic Utricle Function, And Prostatitis Recovery

Prostazen is a Oral Capsule in the Human Otc Drug category. It is labeled and distributed by Hcbiopharm Llc. The primary component is Reynoutria Japonica Root; Rubia Cordifolia Root; Saw Palmetto.

Product ID80353-702_e665cf4f-4a7e-783f-e053-2a95a90ad3b3
NDC80353-702
Product TypeHuman Otc Drug
Proprietary NameProstazen
Generic NameEnlarged Prostate, Prostatic Utricle Function, And Prostatitis Recovery
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-01-12
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHCBIOPHARM LLC
Substance NameREYNOUTRIA JAPONICA ROOT; RUBIA CORDIFOLIA ROOT; SAW PALMETTO
Active Ingredient Strength1 [hp_X]/1; [hp_X]/1; [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 80353-702-01

1 BOTTLE in 1 BOX (80353-702-01) > 1 CAPSULE in 1 BOTTLE (80353-702-02) > 60 CAPSULE in 1 CAPSULE (80353-702-03)
Marketing Start Date2022-01-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Prostazen" or generic name "Enlarged Prostate, Prostatic Utricle Function, And Prostatitis Recovery"

NDCBrand NameGeneric Name
80353-702ProstazenEnlarged Prostate, Prostatic Utricle Function, and Prostatitis Recovery
80353-700HerbCiti Prostazen 60CapsEnlarged Prostate, Prostatic Utricle Function, and Prostatitis Recovery

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.